Analytical quality by design (AQbD) based optimization of RP-UPLC method for determination of nivolumab and relatlimab in bulk and pharmaceutical dosage forms

Analytical quality by design (AQbD) based optimization of RP-UPLC method for determination of nivolumab and relatlimab in bulk and pharmaceutical dosage forms

Abstract Background The Analytical Quality by Design (AQbD) methodology extends the application of Quality by Design (QbD) principles to the management of the analytical procedure life cycle, encompassing method creation, optimization, validation, and continuous improvement. AQbD assists in creating...

Full description

Bibliographic Details
Main Authors: Mohana Vamsi Nuli, Ramanjaneyulu Seemaladinne, Anil Kumar Tallam
Format: Article
Language:English
Published: SpringerOpen 2024-07-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Analytical quality by design
Nivolumab
Relatlimab
Central composite design
Reversed-phase ultra-performance liquid chromatography
Online Access:https://doi.org/10.1186/s43094-024-00659-5

Internet

https://doi.org/10.1186/s43094-024-00659-5

Similar Items